Molecular β-adrenergic signaling abnormalities in failing rabbit hearts after infarction.

We studied alterations in the β-adrenergic receptor (β-AR) system of rabbit hearts during the development of heart failure (HF) after myocardial infarction (MI) to determine whether the molecular β-AR abnormalities associated with human HF exist in this animal model. Rabbit HF was established 3 wk after left circumflex coronary artery (LCX) ligation by in vivo physiological measurements, and molecular β-AR signaling was examined in tissue and cultured ventricular myocytes. We found that there was a significant global reduction in β-AR density by ∼50% in both ventricles of MI animals compared with sham-operated control animals and that functional β-AR coupling was significantly reduced. Importantly, as found in human HF, myocardial protein levels and activity of the β-AR kinase (β-ARK1) and Gαi were found to be significantly elevated in MI rabbits, suggesting that these molecules are contributing to myocardial dysfunction. Thus the myocardial β-AR system of this rabbit model of HF shares important biochemical characteristics with human HF and therefore is an ideal laboratory model to investigate novel therapeutic targets for the treatment of HF.

[1]  Robert,et al.  The Binding Site for the @ r Subunits of Heterotrimeric G Proteins on the @-Adrenergic Receptor Kinase * , 2001 .

[2]  ICHAEL,et al.  THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE , 2000 .

[3]  R. Lefkowitz,et al.  Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. , 1998, Circulation.

[4]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Lefkowitz,et al.  Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Goldman,et al.  Echocardiographic changes after myocardial infarction in a model of left ventricular diastolic dysfunction. , 1997, American journal of physiology. Heart and circulatory physiology.

[7]  P. Ping,et al.  Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. , 1997, The American journal of physiology.

[8]  W. Koch,et al.  Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase* , 1997, The Journal of Biological Chemistry.

[9]  R. Lefkowitz,et al.  Gene transfer strategies for augmenting cardiac function. , 1997, Trends in cardiovascular medicine.

[10]  J. Ross,et al.  Animal models of heart failure recent developments and perspectives. , 1997, Trends in cardiovascular medicine.

[11]  M. Drazner,et al.  Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. , 1997, The Journal of clinical investigation.

[12]  R. Lefkowitz,et al.  Restoration of b-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer , 1997 .

[13]  R. Lefkowitz,et al.  Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Lohse,et al.  Activation of β-Adrenergic Receptor Kinase During Myocardial Ischemia , 1996 .

[15]  K. Swedberg,et al.  The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. , 1996, American heart journal.

[16]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[17]  R. S. Williams Boosting cardiac contractility with genes. , 1995, The New England journal of medicine.

[18]  K. Mahaffey,et al.  Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue. , 1995, Circulation.

[19]  J. Port,et al.  Reduced beta 1 receptor messenger RNA abundance in the failing human heart. , 1993, The Journal of clinical investigation.

[20]  R. Lefkowitz,et al.  Structure and mechanism of the G protein-coupled receptor kinases. , 1993, The Journal of biological chemistry.

[21]  M. Bristow Changes in myocardial and vascular receptors in heart failure. , 1993, Journal of the American College of Cardiology.

[22]  R. Lefkowitz,et al.  The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. , 1993, The Journal of biological chemistry.

[23]  M. Böhm,et al.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.

[24]  M. Lohse,et al.  Altered Expression of, ‐Adrenergic Receptor Kinase and 1‐Adrenergic Receptors in the Failing Human Heart , 1993 .

[25]  O. Brodde Beta-adrenoceptors in cardiac disease. , 1993, Pharmacology & therapeutics.

[26]  J. B. Higgins,et al.  Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. , 1992, Science.

[27]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[28]  J. Port,et al.  Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. , 1989, Molecular pharmacology.

[29]  W. Baumgartner,et al.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.

[30]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.